中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

小剂量米非司酮治疗子宫肌瘤60例临床效果观察

刘金玲

(陕西省商洛市商南县医院妇产科,陕西 商洛,726300)

浏览次数:91次 下载次数:385次

摘要:

目的 探究应用小剂量米非司酮治疗子宫肌瘤的临床效果。方法 选取2014年6月至2015年6月我院门诊子宫肌瘤患者60例作为本次研究对象,全部给予口服小剂量米非司酮进行治疗,治疗持续时间为3 个月,对比治疗前、后患者临床症状改善情况、子宫体积和子宫肌瘤大小以及卵泡刺激素(FSH)、黄体生成素(LH)、雌激素(E2)、孕酮(P)、泌乳素(PRL)和雄激素(T)的血清含量水平。结果 治疗后,大部分患者月经量明显减少,经期缩短、痛经、下腹坠胀等临床症状均明显改善,部分患者贫血纠正,子宫体积和子宫肌瘤体积均明显缩小,差异具有统计学意义(P<0.05);血清中FSH、LH、E2和P含量显著下降,差异具有统计学意义(P<0.05);PRL以及T的血清含量未发现明显变化,差异不具有统计学意义(P>0.05)。结论 小剂量米非司酮用于治疗子宫肌瘤,能够取得较好的临床效果,可降低患者复发率,减少药物不良反应,适宜在临床中予以推广运用。

关键词:米非司酮;子宫肌瘤;激素

中图分类号:R737.33文献标志码:A文章编号:2096-1413(2017)03-0046-02

    Clinical efficacy observation of small dose of mifepristone in treatment

     of 60 cases of uterine fibroid patients
    LIU Jin-ling
    (Department of Obstetrics and Gynecology, Shangnan County Hospital, Shangluo 726300, China)

    ABSTRACT: Objective To explore the clinical effect of small dose of mifepristone in the treatment of uterine fibroid. Methods Sixty cases of uterine fibroid patients admitted in the outpatient department of our hospital from June 2014 to June 2015 were selected as the research objects. All patients were treated with small dose of mifepristone orally, the treatment duration was three months. The improvement of clinical symptoms, the size of uterine volume and uterine fibroid, the level of FSH, LH, E2, P, PRL and T were compared. Results After the treatment, the menstrual blood loss reduced remarkably, and other clinical symptoms like menstrual period reduction, dysmenorrhea, lower abdomen bulge were improved remarkably, a part of patients with anemia was cured,the size of uterine volume and uterine fibroid were all shrinked, the difference was significant (P<0.05); the levels of FSH, LH, E2, P were reduced, the difference were significant (P<0.05). However, there was no statistical difference in PRL and T (P>0.05). Conclusion Small dose of mifepristone can achieve better clinical efficacy in treatment of uterine fi-broid, with decreased recurrence rate, and less adverse drug reactions, which is suitable to apply in clinic.
    KEYWORDS: mifepristone; uterine fibroid; hormone

    参考文献:
    [1] 黄起.小剂量米非司酮治疗子宫肌瘤90例临床观察[J].临床和实验医学杂志,2010,9(12):931-932.
    [2] 张长伟,邱昭平.米非司酮治疗子宫肌瘤207例临床观察[J].中国社区医师:医学专业,2010,12(27):58.
    [3] 程金华,张玉荣,毛为会.米非司酮治疗子宫肌瘤52例临床观察[J]. 中国实用妇科与产科杂志,2003,19(1):49-50.
    [4] 胡惠英.腹腔镜子宫肌瘤剔除术前米非司酮预处理的临床效果观察[J].实用药物与临床,2014,17(3):381-383.
    [5] 谢漫漫.观察不同剂量米非司酮治疗子宫肌瘤的临床效果[J].临床合理用药杂志,2014,7(9):67-68.

上一篇急性重症胰腺炎早期CRRT治疗疗效评估

下一篇丙戊酸钠联合拉莫三嗪应用于各型癫痫病治疗中的临床效果